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ABSTRACT Many components of modern living exert inﬂuence on the resident intesti-
nal microbiota of humans with resultant impact on host health. For example, exercise-
associated changes in the diversity, composition, and functional proﬁles of microbial
populations in the gut have been described in cross-sectional studies of habitual ath-
letes. However, this relationship is also affected by changes in diet, such as changes in
dietary and supplementary protein consumption, that coincide with exercise. To deter-
mine whether increasing physical activity and/or increased protein intake modulates gut
microbial composition and function, we prospectively challenged healthy but sedentary
adults with a short-term exercise regime, with and without concurrent daily whey pro-
tein consumption. Metagenomics- and metabolomics-based assessments demonstrated
modest changes in gut microbial composition and function following increases in physi-
cal activity. Signiﬁcant changes in the diversity of the gut virome were evident in partici-
pants receiving daily whey protein supplementation. Results indicate that improved
body composition with exercise is not dependent on major changes in the diversity of
microbial populations in the gut. The diverse microbial characteristics previously ob-
served in long-term habitual athletes may be a later response to exercise and ﬁtness im-
provement.
IMPORTANCE The gut microbiota of humans is a critical component of functional
development and subsequent health. It is important to understand the lifestyle and
dietary factors that affect the gut microbiome and what impact these factors may
have. Animal studies suggest that exercise can directly affect the gut microbiota,
and elite athletes demonstrate unique beneﬁcial and diverse gut microbiome char-
acteristics. These characteristics are associated with levels of protein consumption
and levels of physical activity. The results of this study show that increasing the ﬁt-
ness levels of physically inactive humans leads to modest but detectable changes in
gut microbiota characteristics. For the ﬁrst time, we show that regular whey protein
intake leads to signiﬁcant alterations to the composition of the gut virome.
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Whey protein-derived bacteriophages
alter the gut virome of physically inactive
volunteers.
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Most of the elements of human lifestyle and environment inﬂuence the composi-tion or function of the gut microbiome (1, 2). Indeed, the microbiome has been
viewed as a transducer of nutrient and other environmental signals for the host (3).
Therefore, several investigators have begun to explore whether a sedentary lifestyle or,
more speciﬁcally, a lifestyle that includes exercise and ﬁtness is associated with changes
in the gut microbiota (4–7). This has been assessed in cross-sectional studies of habitual
exercisers (8–10) and professional athletes (10–12) in addition to experimental models.
In elite athletes, distinct compositional and functional microbial characteristics,
including increased -diversity, enhanced microbial production of short-chain fatty
acids, and greater metabolic capacity, are evident in the gut (11, 12). These microbial
features positively correlate with the athletes’ levels of physical activity, in addition to
the quantity of dietary protein consumed. In many professional sporting disciplines, as
well as amateur sport, intentional protein supplementation (e.g., whey protein) pro-
vides a sizeable proportion of athletes’ daily protein intake (12).
Evidence from animal studies highlights the potential for taxonomic manipulation of
colonic microbiota following exercise interventions, both with and without concurrent
dietary alterations (6, 13, 14). Previously, we have proposed several mechanisms by
which exercise and resultant ﬁtness may directly inﬂuence the gut microbiota, includ-
ing effects on gastrointestinal transit time (15), a known driver of the diversity of
microbial populations in the gut (16, 17). It appears that physical activity initiated in the
juvenile period of development demonstrates a greater potential for fostering a
preferential microbiota than exercise commenced in adulthood (6, 18).
However, the relationship between exercise and alterations in the microbiome in
humans is compounded by changes in dietary consumption that often accompany
physical activity, e.g., increased protein supplement intake.
Building on previous work (11, 12), the present study sought to interrogate corre-
lations between the gut microbiome and levels of physical activity and protein con-
sumption. To do so, using a combination of next-generation shotgun sequencing and
metabolomic analysis, we prospectively examined the impact of exercise, with and
without whey protein supplementation, on the adult human gut microbiome. We
report that 8 weeks of combined aerobic and resistance training led to modest
alterations in the composition and activity of the gut microbiome of sedentary indi-
viduals. Participants consuming whey protein daily did experience a marked alteration
in the diversity of their gut virome following 8 weeks of oral supplementation.
RESULTS
Study overview. Following local advertisement, healthy Irish male and female
Caucasian volunteers (n  90) aged 18 to 40 years and with a body mass index (BMI)
of between 22 and 35 kg/m2 (predominantly overweight or obese) were recruited
between January and August 2014 (Fig. 1). The study was conducted in accordance
with the Declaration of Helsinki, and, prior to commencement, ethical approval was
granted by the Cork Clinical Research Ethics Committee (CREC). All volunteers provided
written informed consent. To prospectively measure the effect of de novo exercise
training on gut microbiota, subjects were required to be physically inactive for at least
3 months prior to study entry (i.e., not engaged in regular structured or unstructured
exercise beyond the light physical activities of daily life). All participants were screened
for speciﬁc exclusion criteria, including regular medication use and history of cardio-
vascular disease (CVD), diabetes mellitus, or autoimmune disorders (see Table S1 in the
supplemental material). Volunteers who had received oral antibiotics or bowel prepa-
rations or had suffered gastroenteritis 1 month prior to study enrollment were ex-
cluded.
Eligible volunteers were randomized into 2 intervention groups: an exercise-only
group (E group) and an exercise plus daily whey protein supplementation group (EP
group) (Fig. 1). A separate parallel group consuming whey protein supplementation but
not participating in exercise programs (P group) was included in the study as a control.
To encourage recruitment to this control group, volunteers were offered an exercise
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program at a later date, but their participation in the program after the conclusion of
the study was not followed extensively. All participants were observed and measured
for 8 weeks (n  30 for each group). The exercise-only group (E) participated in an
8-week mixed aerobic and resistance exercise training program. The exercise plus whey
protein supplementation group (EP) followed the same exercise program, in addition to
consuming the once-daily whey protein supplement. All volunteers were asked
to maintain their usual ad libitum dietary intake during the intervention period and to
refrain from taking additional vitamin, dietary, or herbal supplements.
Participants in the E and EP groups were required to train 3 times per week for
8 weeks. The exercise program consisted of combined aerobic and resistance training.
Aerobic exercise was standardized, progressive, and similar in energy expenditure to a
couch-to-5-km-running program. The intensity of aerobic exercise was moderate,
being graded at between 5 and 7 of 10 on the modiﬁed Borg rating of perceived
exertion (RPE) scale (19). Resistance training consisted of 7 machine-based resistance
exercises. Starting weights were calculated at induction at 70% of the individual’s
one-repetition maximum (1RM) value. Subjects were required to perform a minimum 3
sets of 8 repetitions. Resistance training was progressive, with aims of increasing
resistance weight by 15% to 20% over the 8-week period.
To ensure a uniform and consistent increase in daily protein consumption, subjects
in the P and EP arms of the study were required to take a daily 30-g protein supplement
containing 24 g of whey protein (donated as an unrestricted grant by Carbery Group,
Ballineen, Co. Cork, Ireland). The supplement comprised a blend of whey protein
concentrate, isolate, and hydrolyzed whey protein concentrate (see Table S2 for full
nutritional details). Subjects’ compliance to daily whey protein supplementation was
encouraged using daily text message reminders. Volunteers were required to return
FIG 1 Study design. The ﬁgure presents details of study recruitment and allocation of participants to intervention groups as follows: exercise-only group (E),
exercise and protein supplementation group (EP), and whey protein supplementation-only group (P). Reasons for volunteer dropout and completion numbers
are also outlined. See also Table S1.
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empty whey protein sachets to the study site fortnightly before the issuing of further
supplement. Subjects with a compliance rate of less than 90% were excluded from the
study.
Baseline measurements were not signiﬁcantly different among the three study
groups (Table 1).
Participants were predominantly overweight, with body fat percentages above 30%.
There were no signiﬁcant differences in the participants’ baseline levels of physical
activity as assessed using the International Physical Activity Questionnaire (20). All
baseline values are expressed as medians and interquartile ranges (IQR).
Eight weeks of aerobic and resistance training improves body composition and
cardiorespiratory ﬁtness proﬁles in sedentary subjects. A total of 74 of the 90
participants enrolled in the study completed the 8-week study period (reasons for
dropping out are detailed in Fig. 1). At entry, the intervention groups shared similar
clinical and anthropometric characteristics. Following the intervention period, both E
and EP group participants demonstrated signiﬁcant and similar improvements in
predicted maximal aerobic capacity (VO2max) (Fig. 2A). Furthermore, resting heart rate
was signiﬁcantly reduced following the intervention period in both of the exercising
groups (E and EP) compared with the protein-only group (P  0.005) (Table S3).
Compliance with the prescribed exercise program was high, with a median of 21
sessions (87.5%) performed in both the E and EP groups. The types and levels of
exercise training undertaken in both groups were similar, with no statistically signiﬁcant
differences in the aerobic- and resistance-training workloads recorded (Table S4).
In contrast to the protein-only group, the exercise-only group and the exercise plus
protein supplementation group experienced signiﬁcant decreases in percentage body
fat, total fat mass, and trunk fat mass during the intervention period (Fig. 2B and C), in
addition to an increase in total lean tissue mass (Fig. 2D) (all P  0.001; see also
Table S3). Compliance with daily whey protein supplementation in the EP and P groups
was high with only one participant excluded due to poor adherence to whey protein
supplementation. Whey protein supplementation aside, dietary frequency patterns did
not deviate from the volunteers’ usual intake at study entry (Fig. S1). Addition of the
30 g daily whey protein supplement did not favor the EP over E group with respect to
body composition improvement; however, the study was not designed to test this
TABLE 1 Baseline demographic and anthropometric characteristics of the study
participants with comparisons between the 3 intervention groupsa
Patient characteristic
Values
P value
Exercise (E) only
(n  25)
Exercise  protein
(EP) (n  22)
Protein only
(P) (n  27)
Age (yrs) 35 (28, 38) 32 (28, 35) 34 (28, 36) 0.528
No. (%) of femalesb n  14 (56) n  12 (55) n  11 (41) 0.48
Height (cm) 172 (165, 181) 169 (166, 183) 172 (163, 178) 0.67
Weight (kg) 78.8 (70.1, 94.5) 82.3 (69, 98.9) 76.4 (69.8, 87) 0.67
BMI (kg/m2) 27.9 (25.1, 29.2) 27.5 (25.7, 30) 27 (24.9, 28.7) 0.761
Resting heart rate (bpm) 72 (65, 81) 68 (61, 79) 74 (66, 78) 0.36
Systolic BP (mm Hg) 128 (117, 134) 125 (121, 136) 125 (118, 130) 0.706
Diastolic BP (mm Hg) 78 (74, 89) 76 (72, 84) 79 (75, 84) 0.543
Waist/hip ratio 0.85 (0.83, 0.89) 0.84 (0.8, 0.93) 0.83 (0.78, 0.88) 0.365
Body fat (%) 32.8 (29, 38.7) 34.7 (29, 37.2) 34.5 (29.3, 39.4) 0.659
Fat mass (kg) 26.3 (22.6, 30.6) 26 (23, 33.1) 26.8 (20.7, 32.9) 0.96
Fat mass (trunk) (kg) 14.1 (10.8, 16.8) 14.1 (11.2, 17.6) 13.7 (9.4, 17.1) 0.878
Lean tissue mass (kg) 52.4 (40.7, 61.4) 51.3 (41.5, 61.5) 47.2 (42.9, 53.3) 0.44
Weekly PA (METS) 462 (298, 1,139) 564 (413, 844) 657 (424, 1,145) 0.599
Weekly PA (kCal) 761 (381, 1,618) 748 (525, 1,127) 762 (512, 1,773) 0.767
Sitting time (h per wk) 56 (40, 61) 62 (47, 76) 51 (33, 62) 0.114
Motorized transport (h per wk) 5 (3.25, 8.3) 3.5 (2, 6) 4.1 (0.8, 7) 0.27
aValues represent medians (interquartile ranges) except where otherwise indicated. P values represent results
of Kruskal-Wallis tests or chi-square tests. BMI, body mass index; IPAQ, International Physical Activity
Questionnaire; METS, metabolic equivalents.
bData indicate chi-square test results.
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hypothesis. No clinically relevant differences in resting-state serum proinﬂammatory
markers were evident following any of the interventions (Fig. S2; see also Table S5).
Metagenomic assessment of microbiota after exercise and/or dietary adjust-
ment. Postintervention alterations (percent Δ) in gut microbial -diversity did not
identify signiﬁcant modulation in taxonomic composition or metabolic pathways for
any of the intervention groups compared to baseline (Fig. 3A to D). A trend of median
increase in bacterial diversity was observed for the E and EP groups (Fig. 3B). These
ﬁndings of moderate alterations of -diversity were consistent across pairwise com-
parisons of the groups, with a few notable exceptions. Increased -diversity of Archaea
species in the P group following intervention was observed, as was a moderate
enhancement of archaeal diversity in the P group compared to the EP group (P  0.05
and P 0.01, respectively; Fig. 3E). After the intervention period, bacterial diversity was
greater in the EP group than in the P group (P  0.05; Fig. 3F), while the diversity of
virus species was lower in EP group than in the E group (P  0.05; Fig. 3G).
Principal-coordinate analysis (PCoA) was used to present separation of measures
from the taxonomic composition and metabolic pathway models (Fig. 3H to O). Prior to
intervention, all 3 groups demonstrated similarity in measures of microbial metabolic
pathways and taxonomic -diversity (Fig. 3H to K). A signiﬁcant separation between the
intervention groups was detected in the Bray-Curtis-derived dissimilarity matrices
generated from participants postintervention for metabolic pathways (P  0.054;
Fig. 3L), the entirety of detected species (P  0.001; Fig. 3M), and species of bacteria
(P  0.05) and viruses (P  0.001) (Fig. 3N and O, respectively). Archaea species did not
differentiate with intervention (data not presented).
FIG 2 Alterations in cardiorespiratory ﬁtness and body composition following exercise interventions,
protein interventions, and combined interventions. (A) Peak aerobic capacity (VO2max) per kilogram of body
weight as predicted using the Rockport 1-mi walk test was higher in both the E and EP groups following
the intervention period, indicating improved levels of cardiorespiratory ﬁtness. Within-group comparisons
were tested using the Wilcoxon signed-rank test (P  0.001). (B) Changes in percentages of body fat
following the intervention period as measured using DEXA. Percent body fat reduction was signiﬁcantly
greater in the exercise-only group and in the exercise plus protein supplementation group compared to the
protein-only group. (C) Absolute changes in body fat mass (in kilograms) following the intervention period
demonstrated a signiﬁcantly greater reduction in both the exercise and exercise plus protein supplemen-
tation groups. (D) Absolute change in lean tissue mass (kg), measured using a three-compartment model,
indicating signiﬁcantly greater lean mass accretion in the E and EP groups than in the P group. Error bars
represent 95% conﬁdence intervals. See also Tables S3 to S5.
The Impact of Exercise on the Gut Microbiome
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FIG 3 Intervention effects on taxonomic and functional pathway diversity of the intestinal microbiome. (A to D) Percent change (Δ) of Shannon -diversity
H-index values following intervention. No signiﬁcant variations were presented for taxonomic measurements (A to C) or metabolic pathways (D). (E to G)
Pairwise statistical assessment of taxonomy -diversity demonstrates equal data with respect to the presence of taxonomy between groups at baseline. EP1,
combined exercise and protein supplementation group, week 0; EP2, combined exercise and protein supplementation group, week 8; E1, exercise-only group,
week 0; E2, exercise-only group, week 8; P1, protein-only group, week 0; P2, protein-only group, week 8. (E) The diversity of Archaea was signiﬁcantly altered
after intervention within the P group (P 0.05) and, similarly, was greater in the P group (P2) than in the EP group (EP2) (P 0.01). (F) Postintervention bacterial
diversity was greater in the EP group (EP2) in testing against the P group (P2) (P  0.05). (G) Similar levels of virus diversity were presented in the protein
supplementation groups (EP and P) following the intervention, with signiﬁcantly lower diversity in the EP group than in the E group (P  0.05). (H to O)
Principal-coordinate analysis (PCoA) of relative abundance proﬁles for taxonomic and metabolic pathway constructions of the three groups demonstrates the
inﬂuence of the interventions on the diversity of microbial populations. (H to K) Prior to intervention, group proﬁles of taxonomic and metabolic pathway
(Continued on next page)
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Pairwise analysis of taxonomy compared according to high-level phylogeny (Ar-
chaea, Bacteria, and viruses) demonstrated signiﬁcant alterations of detected virus
species in both the EP and P groups following the intervention period that were absent
from the exercise-only group (P  0.001; Fig. 4). There were no further signiﬁcant
separations for Archaea or Bacteria species or for metabolic pathways (Fig. S3A to I). An
unsupervised partial-least-squares–discriminant analysis (PLS-DA) approach was used
to identify underlying features of the metabolic pathways before and after the inter-
vention period (Fig. S3J and K). Pathways associated with Prevotella copri were shown
to cluster with the E group prior to intervention. Following intervention, this cluster was
still present but, in addition, separate clusters of P. copri- and Bacteroides vulgatus-
associated pathways were apparent within the EP and P groups, respectively. Forty-
eight species were detected as being differentially abundant within the three groups
(false-discovery rate [FDR]  0.05). The majority of identiﬁed taxa were virus species,
predominantly Lactococcus phage, within the P and EP groups. No Archaea were found
to have signiﬁcantly varied in abundance with treatment in any of the groups (Ta-
ble S6).
Of the total 23,019 unique (e.g., coenzyme A biosynthesis) and taxonomically
speciﬁc (e.g., coenzyme A biosynthesis in Akkermansia muciniphila) metabolic pathways
included in the metagenomic construction of the models, 619 were identiﬁed as having
signiﬁcantly differed among the three intervention groups at either the pretreatment or
posttreatment time point (P  0.05). Signiﬁcantly altered pathways were organized
according to a metabolic pathway hierarchy deﬁned by the MetaCyc database and
were structured as a heat map of low-level categories of classiﬁcation (e.g., nucleotide
biosynthesis) (Fig. S4). Scaled group means of pathway relative abundances demon-
strated modest alterations of microbial metabolic potential. A complete list of the
categorized pathways can be found in the supplemental material (Table S6). Further
assessment of pathways differing among all groups was performed both within each
group (before and after treatment) and between the separate groups. No signiﬁcant
variation within groups was evident following P value correction for multiple testing.
Untargeted metabolomic analysis of participant fecal-water and urinary samples
revealed no signiﬁcant separations either within each group pre- and postintervention
or between groups at each time point with analysis of the full spectrum of metabolites.
Subsequent targeted metabolomic quantiﬁcation, guided by previous ﬁndings (11, 70,
71), revealed signiﬁcant changes following intervention in the amount of glutamate
(fecal water) and trans-aconitate (urine) in the protein-only group (P  0.01 and P 
0.05, respectively; Table S6). Comparisons of differences (percent Δ) in metabolite
quantiﬁcations between all groups demonstrated signiﬁcant variation in the levels of
phenylacetylglycine (PAG) and trimethylamine N-oxide (TMAO) (P  0.01 and P  0.05,
respectively) in urine, as well as of glutamate (P 0.05) in fecal water, within all groups
(Table S6). Such differences were also present in the paired comparisons. Levels of both
PAG and TMAO were signiﬁcantly reduced (Δ  0.196 and 0.518, respectively) in
the E group following the intervention period in comparison to the P group (P  0.05,
Table S6).
Characterization of whey protein supplement microbial content. Metagenomic
sequencing of the whey protein supplement and of a non-dairy-based dietary supple-
ment control revealed a taxonomic proﬁle in the former that was characterized by high
proportions of bacteriophage associated with lactic acid bacteria. Notably, these phage
were also enriched in participants in receipt of the whey supplement (Table S6). The
FIG 3 Legend (Continued)
diversity were not signiﬁcantly differentiated. (L to O) Following intervention, a signiﬁcant separation was identiﬁed between the groups for measures of (L)
metabolic pathways (P  0.054), (M) all detected species unsegregated by phylogeny (P  0.001), (N) bacteria (P  0.05), and (O) virus species (P  0.001).
Speciﬁc separations in diversity per intervention group are outlined further in Fig. 4 for virus species and Fig. S3 for all other comparisons. Statistical assessment
of PCoA dissimilarity matrices was performed with the Adonis2 permutational multivariate analysis of variance (PERMANOVA) test. (H to O) Density plots were
derived from kernel density estimates and scaled to a maximum estimated value of 1 and display concentrations of plotted data along the corresponding plot
axis. P values were calculated for -diversity comparisons using the Wilcoxon signed-rank test.
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FIG 4 Pairwise analysis of detected virus taxonomy prior to and following intervention. (A to C) PCoA
of virus species for each group, comparing virus proﬁles before and after the intervention period (time
point 1 [TP1] [week 0] and time point 2 [TP2] [week 8], respectively). (A) The exercise-only group had virus
diversity that was not signiﬁcantly altered by intervention. (B and C) Diversity of viruses was signiﬁcantly
affected during the intervention period for both groups receiving protein supplementation (P  0.001).
The exercise plus protein supplementation group (B) and the protein-only group (C) demonstrated
(Continued on next page)
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taxonomic composition of the whey protein and control demonstrated highly diver-
gent microbial contents of the supplements, including taxa detected in participants.
DISCUSSION
To accurately and consistently increase daily protein intake, we selected a whey
protein supplement. Whey protein, a widely used commercial supplement in elite sport
and amateur ﬁtness milieu, is known for its muscle accretion effects (21), in addition to
its positive inﬂuence on energy metabolism (22–24) and, more recently, on appetite
control (25). In addition, its use facilitated analysis of the effect of a widely available
exercise adjunct on the diversity, composition, and activity of microbial populations in
the gut. Somewhat unexpectedly, individuals in the whey protein supplementation-
only group (P) experienced a signiﬁcant alteration in the -diversity of the gut virome
(Fig. 4C). Furthermore, this change was mirrored in the combined exercise and protein
supplementation (EP) group (Fig. 4B), suggesting a robust effect of whey protein on the
taxonomic richness of the gut virome. To explore this dynamic, a sample of the whey
supplement and a sample of a non-dairy-based dietary supplement were sequenced for
microbial content. Intriguingly, all bacteriophage and two of the four bacterial species
that were signiﬁcantly altered in the groups receiving whey protein were present in
high relative abundance within the whey protein supplement but not the control
supplement. Further in-depth experimentation is required to determine whether vi-
rus particles from whey protein conclusively transmit to the human gut from consump-
tion and, if so, whether they remain biologically active. However, the overlap in the
taxonomic compositions of the whey supplement and participants’ gut microbiome
provides a convincing explanation for the source of virome changes observed.
While this examination did not identify a signiﬁcant impact of short-term combined
aerobic and resistance exercise on the diversity of bacterial or archaeal constituents of
the gut microbiome, subtle compositional and functional changes were detected in this
analysis (Fig. 3 and 4; see also Fig. S3 and S4). Although the results were not statistically
signiﬁcant, the groups engaged in exercise demonstrated less change in archaeal
diversity than the protein-only group after the intervention period. In the case of the
exercise-only group, a reduction in Archaea diversity was observed, suggesting that
exercise acts against intestinal Archaea. More-extensive investigation is necessary to
resolve this issue, but in view of a putative role for Archaea in intestinal disorders and
as modulators of TMAO concentrations, such an inquiry is justiﬁed (26). Changes in
Bacteria diversity were similarly below the threshold of statistical signiﬁcance; however,
the median differences between groups indicated that those undertaking exercise had
increases in bacterial diversity that were absent from the intervention group excluded
from exercise. Curiously, the diversity of bacterial species was elevated in the EP group
after intervention but the diversity of virus species was uniformly lower. The inverse
relationship of these measures is counterintuitive given the predominance of bacte-
riophage in the detected viruses. However, the inﬂux of such bacteriophage may
explain the overall reduction of virus diversity within the group. Furthermore, this
increase in the levels of bacteriophage may have been insufﬁcient to profoundly
inﬂuence the overall diversity of the Bacteria due to their selective targeting of only a
few bacterial species.
The absence of substantial modulation of the diversity of microbial populations in
the gut following the 8-week exercise intervention mirrors recent ﬁndings in mice (27).
To date, most of the work in humans has focused on elite or professional athletes
(10–12) and as a result has explored the relationship between established physical
FIG 4 Legend (Continued)
reduced variability of diversity following intervention. Results of pairwise analysis of additional taxo-
nomic and metabolic pathway proﬁles are presented in Fig. S3. Statistical assessment of PCoA dissimi-
larity matrices was performed with the Adonis2 PERMANOVA test. (A to C) Density plots were derived
from kernel density estimates and scaled to a maximum estimated value of 1 and display concentrations
of plotted data along the corresponding plot axis.
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“ﬁtness” and the gut microbiota. Few prospective studies have examined the effect of
exercise on the gut microbiota of physically inactive human volunteers (28). The current
study is the largest to have done so. It should be acknowledged that the unperturbed
adult intestinal microbiome is resilient (29) and may not be subject to signiﬁcant
alteration following an 8-week intervention period. It is likely that the diverse, meta-
bolically favorable intestinal microbiome evident in the elite athlete is the cumulative
manifestation of many years of optimized nutrition and of high degrees of physical
condition throughout youth and adolescence and during adult participation in profes-
sional sports (30). Initial examination of the acute effects of extreme and prolonged
endurance exercise, such as in trained military regiments, suggests that prolonged
physical stress negatively impacts intestinal permeability and gut microbiota compo-
sition (31). However, the results of the present study indicate that exercise at moderate
intensity does not exert a deleterious effect on gut microbial composition or function
in the untrained subject. Furthermore, the results of this study signify that exercise-
induced improvements in cardiorespiratory ﬁtness and body composition are not
dependent on substantial alteration of the diversity of microbial populations in the gut.
Whether the limited changes in microbiome composition and function detected in this
study contributed to the witnessed improvements in body composition and ﬁtness
proﬁles remains unknown.
An intriguing exception to the otherwise minimal differences in metabolomic
modiﬁcation is represented by the controversial metabolite TMAO. Associations be-
tween TMAO and cardiovascular disease (CVD) have framed the metabolite as a disease
factor; however, high levels have also been observed in populations with low CVD risk
(32–35). Elevated levels of TMAO have previously been found in elite athletes (11), and
while the presence of TMAO may or may not have deleterious health implications, we
demonstrate a potential modulatory effect of exercise on urinary TMAO levels. Partic-
ipants in the exercise-only group showed levels of urinary TMAO that were reduced
below baseline with intervention, while the groups receiving whey protein had in-
creased levels of the metabolite, with the combined-treatment group demonstrating
lower levels than the protein-only group. The TMAO precursor phosphatidylcholine
comprised less than 0.1% of the constituents of the whey protein supplement used in
this study, suggesting a possible direct effect of whey protein and/or exercise on TMAO
production. While the data represent a promising paradigm, further work will be
necessary to determine the speciﬁc mechanisms involved and to rule out unintended
dietary inﬂuence or inﬂuences of host biology (e.g., altered absorption of TMAO with
exercise). Additionally, known microbial producers of TMAO (36) were absent from the
taxonomic proﬁling. PAG concentrations were similarly reduced in the exercise-only
group, although the metabolite has previously been associated with lean body com-
position and has been found to be present in increased concentrations in athletes. It
has also recently been shown to decrease in urine in thoroughbred racehorses follow-
ing exercise (37).
Likewise, the data reﬂecting an increase in the abundance of the P. copri-associated
pathways detected in the EP group postintervention supports the work of others which
suggested an active role for Prevotella species in host metabolic (38, 39) and immune
health (40). Studies have linked Prevotella with inﬂammatory and metabolic disorders,
including rheumatoid arthritis (41, 42), ankylosing spondylitis (43), and type 2 diabetes
mellitus (44). Conversely, and consistent with our ﬁndings, increased physical activity
has been associated with increases in Prevotella-related metabolic pathways in the gut
microbiome (10).
It is pertinent to acknowledge the difﬁculty in controlling all potential confounders
of gut microbial composition and activity in this investigation (e.g., diet, wide BMI
range). This study attempted to control for the potential impact of dietary variation by
instruction of volunteers to maintain their usual ad libitum dietary intake. Food fre-
quency questionnaire (FFQ) dietary analysis indicated stability in the volunteers’ dietary
patterns; however, like all self-reported methods of dietary intake assessment, FFQ
assessment is subject to its limitations, including recall bias (45).
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In conclusion, this prospective examination demonstrated that short-to-medium-
term combined exercise in healthy, physically inactive adults does not induce drastic
alterations in the diversity of bacterial, viral, and archaeal populations in the gut. We
highlight an interaction between whey protein intake and the -diversity of the adult
gut virome which requires further exploration. Furthermore, the functional activity of
the gut microbiota does not appear to be extensively manipulated by short-term,
moderate-intensity exercise and/or whey protein supplementation, although some
changes, including alteration of levels of urinary TMAO and PAG excretion, were
evident. The alterations in the diversity, composition, and metabolomic proﬁles of
microbial gut populations that we and others have observed in habitual exercisers and
professional athletes may represent late responses to exercise or ﬁtness.
MATERIALS AND METHODS
Experimental models and subject details. A description of the human study model used here is
outlined in Results under “Study overview.” Male and female volunteers were enrolled. The Cork Clinical
Research Ethics Committee (CREC) approved the study before it commenced. Recruitment and assign-
ment of interventions are outlined in detail below.
Study recruitment and safe participation. Male and female participants, aged between 18 and 40
years (inclusive), were recruited via online, e-mail, and poster advertisement of the study details. This
information was circulated to the study institutions (University College Cork and Cork University Hospital)
and local businesses in Cork City, Ireland. Participants were informed that free gymnasium membership
would be supplied for the study period. Interested individuals contacted researchers via the study
telephone line and were screened initially for inclusion criteria (see Table S1 in the supplemental
material). Baseline levels of physical activity were assessed using the International Physical Activity
Questionnaire short form (46). If appropriate, a subsequent screening visit at the study site was arranged
for further assessment of the exclusion criteria. Safe participation in the exercise program was ensured
by medical screening of all participants using an adapted version of the safe participation questionnaire
of the American College of Sports Medicine (47).
Intervention group allocation. Eligible volunteers were randomized into 2 intervention groups,
namely, an exercise-only group (E group) and an exercise plus daily whey protein supplementation
group (EP group) (Fig. 1). A separate parallel group consuming whey protein supplementation alone (P
group) was included in the study as a control. Participants in the P group were instructed to maintain
their usual levels of light physical activity. To encourage recruitment to the control group, volunteers
were offered an exercise program at a later date but were not followed extensively during that period.
All participants were observed and their responses measured for 8 weeks (n  30 for each group).
Combined exercise intervention. Combined aerobic and resistance training was performed at the
Mardyke Arena gymnasium at University College Cork, Ireland. All exercise sessions took place at this
venue. Volunteers in the P group were asked to maintain their usual levels of physical inactivity for the
8-week period. Participants in the E and EP groups were instructed to adhere to the assigned exercise
program and to avoid additional (moderate to vigorous) physical activity outside that prescribed.
Participants were instructed to train 3 times per week for the 8-week intervention period. Participants
received instructions with respect to the format of the required training program during a 90-min
induction session with designated gym instructors. This induction included demonstration of all aerobic
and resistance training equipment and the opportunity to ask questions when required. Resistance
training machines were customized for individual differences in ranges of motion, and the participants
were observed during use of all of the machines, with instructor feedback and correction. For resistance
machines, 1-repetition maximum (1RM) values were calculated using standardized methods (48).
The outline of the exercise sessions was as follows. After a 5-min warmup on the treadmill (brisk
walking at approximately 4 km/h; modiﬁed Borg RPE, 3 to 5/10), participants underwent aerobic training
of moderate intensity (modiﬁed Borg RPE, 5 to 7/10). To encourage compliance with the prescribed RPE
scales, volunteers were reminded of the desired intensities on each of their weekly exercise training
programs. The aerobic exercise progressed in duration on a weekly basis but remained of moderate
intensity. Initially, aerobic exercise lasted approximately 18 min; by week 8 of the intervention period, the
duration of aerobic exercise increased to approximately 32 min depending on the type of aerobic activity
chosen by the volunteer. Participants were provided with a choice of aerobic activities, including
treadmill jogging/running, use of a cross-trainer device (with no added resistance), use of a stepper
machine, and stationary cycling (with mild resistance). The duration for each of these activities was
calculated based on the 2011 Compendium of Physical Activities (49) to ensure similar levels of energy
expenditure across all activities. To allow variety and to maintain interest, participants were provided
with an option of aerobic activities, provided that they did not change exercises within a given training
session.
Upon completion of the aerobic exercise activity, participants undertook machine-based resistance
training. In summary, participants were required to perform a minimum of 3 sets of 8 repetitions on
7 different resistance machines (3 exercising the upper body, 3 exercising the lower body, and 1
exercising the core muscles). The allowed resistance machine options were as follows: for the upper
body, shoulder press, chest press, lateral pulldowns, and seated rowing; for the lower body, leg
extension, leg curl, gluteal kick-back, and leg press; for the core muscles, abdominal curls and torso
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rotation. A minimum limit of 3 sets of 8 repetitions was instituted, with a maximum limit of 3 sets of 12
repetitions. Starting weights were calculated at induction to correspond to 70% of the individual’s
one-repetition maximum (1RM) value. Resistance training was progressive, with the aim of increasing the
resistance weight by 15% to 20% over an 8-week period. Free-weight use was not permitted.
Compliance and withdrawal from the study. Compliance with the prescribed exercise program
was monitored remotely by the investigators using a FitLinxx activity monitoring system (Activelinxx,
Shelton, CT). All volunteers were provided with a unique identiﬁcation number for the FitLinxx physical
activity recording system and were required to log in and record all activities undertaken at the Mardyke
Arena gym during training. Using this tracking system, compliance with the prescribed exercise program
was monitored by the investigators. Similarly, the quantity of aerobic and resistance training performed
by participants was recorded (Table S4). The FitLinxx software program enables accurate recording of the
duration and frequency of training and provides an estimate of energy expenditure during aerobic
training. The facility’s FitLinxx software and hardware were subjected to maintenance and recalibration
prior to commencement of the study.
Participants noted to have not complied with the exercise regime for more than 7 consecutive days
were withdrawn from the study. Individuals requiring antibiotics during the intervention period were
also withdrawn from the study, as were participants not complying with whey protein intake require-
ment in the EP and P groups.
Measurement visits. Measurement visits took place at 2 sites: Cork University Hospital and the
Mardyke Arena, University College Cork. Baseline measurement was conducted within the 4 days prior
to the commencement of the intervention period and once more after the 8-week intervention.
Participants were asked to refrain from the use of alcohol and medication and moderate to vigorous
physical activity for at least 24 h prior to measurement. To minimize potential effects of diurnal variation,
measurement visits took place between 7:00 a.m. and 10:30 a.m. Initially, participants attended the
Department of Medicine research facility at Cork University Hospital and sat restfully in a quiet
environment. Participants proceeded to participate in measurement of clinical variables, e.g., recording
of weight, blood pressure, and heart rate, before undergoing phlebotomy by a trained nurse using
universal precautions. Approximately 16 ml of venous blood was withdrawn. Plasma and serum samples
were transported immediately to the clinic laboratories at the Mercy University Hospital, Cork. Standard-
ized laboratory techniques were employed for the measurement of hematology and biochemistry
indices. Following phlebotomy, individuals underwent a total body dual-energy X-ray absorptiometry
(DEXA) scan to assess body composition. When possible, volunteers were asked to provide fresh urine
and fecal samples, which were transported at room temperature to Teagasc Moorepark, Fermoy, Co.
Cork, where DNA extraction took place. Following completion of the body composition assessment,
participants proceeded to the indoor track at the Mardyke Arena gymnasium to undergo a submaximal
cardiorespiratory ﬁtness assessment as described below.
VO2max and body composition measurement. To prevent injury from unaccustomed vigorous
exercise, we chose a submaximal assessment of peak aerobic capacity. Baseline and postintervention
levels of cardiorespiratory ﬁtness were measured using a validated submaximal ﬁtness test (50). The
Rockport 1-mi walk test was performed in a standardized temperature environment at the indoor
running track of the Mardyke Arena. This test was used to estimate maximal oxygen uptake (VO2max).
A Lunar iDXA machine (GE Healthcare, Madison, WI) at the Bone Densitometry Unit, Cork University
Hospital, was used. Body composition was analyzed using enCORE software (V.13.4, 2010) and a
three-compartment (fat mass, bone mass, lean tissue) body composition model. Volunteers were
scanned postvoiding and dressed in light clothing, with metal-wear removed where present. Quality
control (QC) analysis was performed on the iDXA machine before use of the machine on each
measurement day.
Inﬂammatory cytokine measurement. Blood samples (4 ml) from participants were collected in
serum separator clot activator blood collection tubes (Greiner Bio-One, Stonehouse, United Kingdom;
reference no. 454071). The blood samples were allowed to rest upright on the laboratory bench for
30 min before centrifugation was performed at 1,000  g for 20 min at room temperature. Approxi-
mately 2 ml of supernatant sera was then harvested by pipette, frozen, and stored at 80°C in
polypropylene cryogenic vials. At a later date, following a complete thaw, resting levels of proinﬂam-
matory cytokines were measured using a mesoscale discovery (MSD) platform (Meso Scale Discovery,
Rockville, MD). The MSD system is an electrochemiluminescence-based solid-phase multiplex assay. An
ultrasensitive human proinﬂammatory I, V-Plex immunoassay panel containing interleukin-6 (IL-6), IL-8,
tumor necrosis factor alpha (TNF-), IL-10, and gamma interferon was used to measure serum levels.
Samples were diluted 1:2 according to the manufacturer’s protocol, and samples from all 3 intervention
groups were dispersed across each MSD plate. The lower limit of detection was 1 pg/ml for all assays.
All plasma samples were measured in duplicate, and the mean cytokine concentration of the duplicates
(in picograms per milliliter) was used for analysis.
Dietary data collection. Dietary data were collected by means of a 146-item food frequency
questionnaire (FFQ) as outlined previously (12). Participants were asked to record their usual pattern of
dietary intake over the previous 8 weeks. The FFQ used was an adapted version of the questionnaire used
in the United Kingdom arm of the European Prospective Investigation into Cancer (EPIC) study (51),
which was based on the original Willet FFQ (52). Completed FFQs were coded and dietary data were
visualized with correspondence analysis using the ade4 package (53) in the R programing environment
(V.3.3.2).
DNA extraction and metagenomic sequencing of fecal microbiome and whey protein supple-
ment. DNA was extracted from the donated fresh fecal samples received at the Teagasc Moorepark
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research facility using a QIAmp DNA stool minikit (Qiagen, Crawley, West Sussex, United Kingdom) (54).
Samples were provided by participants as partial evacuations into sterile containers and, when not
immediately transported for DNA extraction, were held at 4°C for no more than 12 h. Samples were
prepared for DNA extraction by manual homogenization of a portion of the sample representing all
microenvironments (i.e., core and external surface) of the feces. The provided manufacturer’s protocol
was used with modiﬁcation whereby a zirconia bead (Stratech Scientiﬁc) cell disruption bead-beating
step (performed three times for 30 s each time) was introduced in order to enhance homogenization of
the extraction material. DNA extracts and the remaining fecal samples were subsequently stored at
80°C until they were prepared for sequencing.
Metagenomic libraries were prepared using an Illumina Nextera XT DNA library preparation kit
(Illumina Inc., USA) in complete accordance with the manufacturer’s protocol (15031942; Illumina).
Library input DNA was normalized to 0.2 ng/l using ﬂuorometric quantiﬁcation and Qubit system 2.0
(Thermo, Fisher). Library fragmentation and ampliﬁcation were performed using a G-Storm GS1 thermal
cycler, with subsequent library puriﬁcation achieved with AMPure magnetic beads (Beckman Coulter,
Inc.) at a DNA/AMPure ratio of 1:1.8. Conﬁrmation of the sizes of the library fragments was carried out
on an Agilent 2100 Bioanalyzer system, with ﬁnal assessment of library molar concentration (2 nM)
performed using a Roche LightCycler 480 instrument (Roche Applied Science) and a Kapa library
quantiﬁcation kit (Kapa Biosystems). A total of 8 equimolar library pools of samples were made prior to
shipping of the pools on dry ice for sequencing on an Illumina Hiseq 2500 (chemistry V.4.0) sequencing
platform (Beckman Coulter, Inc.; Genomics Inc., Danvers, MA). High-throughput sequencing was per-
formed using the high-output run mode for 2  125-bp paired-end reads with the addition of a PhiX
library (1%) to estimate sequence quality. A sample of the whey protein used in the study and a sample
of an oat-based nutritional supplement used as a control were both processed in a manner identical to
that used with the fecal samples for the extraction of microbial DNA and preparation of metagenomic
libraries. Sequencing of the supplement libraries was performed using an Illumina MiSeq (chemistry
V.3.0) platform in high-output run mode for 2  300-bp paired-end reads (Teagasc sequencing facility).
Bioinformatic processing of microbial metagenomic sequencing. Processing of metagenomic
FASTQ sequence ﬁles proceeded with the removal of human-derived contaminant sequences with NCBI
Best Match Tagger (BMTagger) software, while trimming and removal of duplicate reads or of reads of
substandard quality were performed with Picard and SAM tools. Functional proﬁling of high-quality
processed reads was facilitated by use of the Human Microbiome Project (HMP) Uniﬁed Metabolic
Analysis Network (HUMAnN2 V.0.99) pipeline (55). Models of microbial metabolic pathways produced by
HUMAnN2 were derived from the MetaCyc database (56) and were the basis for analyses performed on
microbial metabolic proﬁling. Taxonomic proﬁling was facilitated by use of the Kraken taxonomy
assignment software tool (V.0.10.6) (57).
Metabolomic sample preparation. Samples were stored at 80°C prior to analysis. Urine samples
were subjected to vortex mixing and then centrifuged at 1,600  g for 10 min to remove precipitated
proteins and particulates. For metabolic proﬁling analysis by reversed-phase (RP) and hydrophilic
interaction chromatography (HILIC) ultraperformance liquid chromatography-mass spectrometry (UPLC-
MS), samples were prepared as follows: 200 l of supernatant was diluted (1:1) with high-purity
(ultraperformance liquid chromatography [HPLC]-grade) water, subjected to vortex mixing, centrifuged
at 2,700  g for 20 min, and divided into aliquots for analysis. Quality control (QC) samples were
prepared by pooling 50-l volumes of each sample. For 1H nuclear magnetic resonance (1H-NMR)
spectroscopy, each sample contained 540 l of urine mixed with 60 l of phosphate buffer (pH 7.4; 80%
D2O) containing a 1 mM concentration of the internal standard, 3-(trimethylsilyl)-[2,2,3,3,-2H4]-propionic
acid (TSP)–2 mM sodium azide (Na3N), as described previously (58). During the analyses, samples were
maintained at 4°C in the autosampler.
Fecal samples underwent two freeze-thaw cycles. Following the freeze-thaw cycles, 100 mg of
homogenized sample was placed in a microtube containing 250 l of 25% acetonitrile (ACN) (1:2
ACN/H2O), 2 mM sodium azide, and ~0.05 g 1-mm-diameter zirconia beads. Each microtube was
processed for 10 s in a Biospec bead beater. Samples were then centrifuged at 16,000  g for 20 min.
The fecal-water supernatant was subsequently centrifuged through centrifuge tube ﬁlters (cellulose
acetate membrane; pore size, 0.22 m) to remove any remaining particulate matter. The centrifuge tube
ﬁlters were washed three times with 25% acetonitrile prior to use. The resulting fecal water was prepared
for UPLC-MS proﬁling using HILIC by diluting 3:1 with acetonitrile and for bile acid proﬁling by diluting
1:1 with isopropanol. Samples were subjected to vortex mixing and incubated at 20°C for 1 h.
Following the incubation step, samples were centrifuged at 4°C at 16,000  g for 1 h and divided into
aliquots for analysis. QC samples were prepared by pooling 20-l volumes of each fecal-water sample
followed by preparation as described above. For 1H-NMR spectroscopy, 50 l of the ﬁltered fecal water
was added to a glass tube (Pyrex), which was placed under a nitrogen gas ﬂow for 30 min or until all the
liquid had evaporated. The dried sample was reconstituted with 540 l of D2O and 60 l of phosphate
buffer solution as described above. The solution was mixed and sonicated for 5 min before undergoing
further centrifugation at 14,000 rpm for 10 min, and then 600 l of the supernatant was transferred to
an NMR tube for 1H-NMR spectral acquisition.
Metabolomic analysis. RP, HILIC, and bile acid UPLC-MS metabolic proﬁling experiments were
performed using a Waters Acquity Ultra Performance LC system (Waters, Milford, MA) coupled to a Xevo
G2 quadrupole-time of ﬂight (Q-TOF) mass spectrometer (Waters, Milford, MA) with an electrospray
source. Samples were analyzed in randomized order, with QC analyzes performed every 10 samples. First,
urine samples were analyzed using UPLC-MS and an RP chromatographic method with both positive and
negative MS ionization modes. Second, to separate and detect the more polar molecules, a HILIC
The Impact of Exercise on the Gut Microbiome
May/June 2018 Volume 3 Issue 3 e00044-18 msystems.asm.org 13
 o
n
 June 14, 2018 by guest
http://m
system
s.asm
.org/
D
ow
nloaded from
 
chromatographic stage was used with the positive MS ionization mode. Fecal-water samples underwent
analysis using HILIC and bile acid proﬁling chromatographic methods in positive and negative ionization
modes, respectively. HILIC, RP, and bile acid proﬁling liquid chromatographic separation procedures were
performed as previously described (59, 60). Mass spectrometry was performed with the following
settings. Capillary and cone voltages were set at 1.5 kV and 30 V, respectively. The desolvation gas level
was set at 1,000 liters/h at a temperature of 600°C. The cone gas level was set to 50 liters/h. The source
temperature was set to 120°C. To ensure the accuracy of the mass data, a lock-spray interface was used,
with leucine enkephalin {556.27741 Da ([MH]), 554.2615 Da ([MH])} solution used as the lock mass
at a concentration of 2,000 ng/ml and a ﬂow rate of 15 l/min.
1H-NMR spectroscopy was performed on the aqueous-phase extracts at 300 K on a Bruker 600-MHz
spectrometer (Bruker Biospin, Germany) using a standard one-dimensional (1D) pulse sequence corre-
sponding to RD  gz1  90°  t1 90°  tm  gz2  90° ACQ (58), where the value of 90° represents
the applied 90° radio frequency pulse; the relaxation delay (RD) was set at 4 s, the interpulse delay (t1)
was set at 4 s, the mixing time (tm) was set at 10 ms, the magnetic ﬁeld gradients (gz1 and gz2) were
applied for 1 ms, and the acquisition period (AQA) was 2.7 s. Water suppression was achieved through
irradiation of the water signal during RD and tm. Urine sample spectra were acquired using 4 dummy
scans followed by 32 scans whereas fecal spectra were acquired using 256 scans and 4 dummy scans and
collected into 64 K data points. A spectral width of 12,000 Hz was used for all the samples. Prior to Fourier
transformation, the free induction decay (FID) values were multiplied by an exponential function
corresponding to a line broadening of 0.3 Hz.
Metabolomic data treatment. The raw mass spectrometric data acquired were preprocessed using
xcms in R. centWave peak picking methods were used to detect chromatographic peaks (61). The
xcms-centWave parameters were data set speciﬁc. Feature grouping across samples was performed
using the “nearest” method within xcms. Peak ﬁlling and MinFrac (0.5), and coefﬁcient of variation (CV)
(0.3) ﬁlters were applied to the features. Data were normalized using median fold change normalization
to the median data set (62).
1H-NMR spectra were automatically corrected for phase and baseline distortions and referenced to
the TSP singlet at  0.0 using TopSpin 3.1 software. Spectra were then digitized into 20 K data points at
a resolution of 0.0005 ppm using an in-house MatLab R2014a (MathWorks, Inc.) script. Subsequently,
spectral regions corresponding to the internal standard ( 0.5 to 0.5) and water ( 4.6 to 5) peaks were
removed. In addition, urea spectra ( 5.4 to 6.3) were removed from the urinary spectra. Spectra were
normalized using median fold change normalization to the median spectrum (62). Combinations of
data-driven strategies, such as SubseT optimization by reference matching (STORM) (63) and Statistical
TOtal Correlation SpectroscopY (STOCSY) (64), and analytical identiﬁcation strategies were used to
identify metabolites of interest from 1H-NMR data sets. Speciﬁcally, a catalogue of 1D 1H-NMR and 2D
NMR experiments was performed using techniques such as J-RESolved spectroscopy, 1H-1H TOtal
Correlation SpectroscopY (TOCSY), 1H-1H COrrelation SpectroscopY (COSY), 1H-13C Hetero-nuclear Single
Quantum Coherence (HSQC), and 1H-13C Heteronuclear Multiple-Bond Correlation (HMBC) spectroscopy.
Finally, for those metabolites giving ambiguous data, e.g., TMAO, the metabolites were conﬁrmed using
in situ spiking experiments and authentic chemical standards. Semiquantiﬁcation data corresponding to
the identiﬁed metabolites were calculated through peak intensity measurements of the normalized
1H-NMR spectra using an in-house script. GC-MS data were processed using MassHunter Quantitative
Analysis (Agilent Technologies) software.
Quantiﬁcation and statistical analysis. Statistical analysis was carried out using the Statistical
Package for the Social Sciences V.23 (SPSS, Inc., Chicago, Illinois) and the R statistical programing
environment (V.3.3.2). Due to the predominance of non-normally distributed data, nonparametric
analyses were performed to compare baseline clinical and demographic variables between groups.
Similarly, nonparametric statistical tests were employed in the analysis of microbiome and metabolomics
data. Clinical data are presented as medians and interquartile ranges (IQR), unless stated otherwise.
Between-group differences in baseline, follow-up, and postintervention changes (Δ) in clinical and
demographic data were compared using the Kruskal-Wallis test. For signiﬁcantly different results, a
Mann-Whitney U test was performed to determine the groups between which this difference applied.
Where stated, the Wilcoxon signed-rank test was used to compare baseline and postintervention values
within intervention groups. A type I error rate of0.05 was considered signiﬁcant in all cases. Correction
of P values relating to microbiome and metabolomic analysis was performed using the Benjamini-
Hochberg false-discovery rate (FDR) (65) in the base stats package in R. Statistical assessment of
dissimilarity matrices (Bray-Curtis) derived from microbial data was facilitated with the adonis2 function
in the vegan R package (V.2.4-3) (66). Identiﬁcation of statistically relevant taxonomic features was
performed with the analysis of composition of microbiomes (ANCOM) test as implemented in the R
package of the same name (V.1.1-3) (67). Detection of underlying features of metabolic pathways was
performed with unsupervised cross-validated partial-least-squares–discriminant analysis (PLS-DA) and
the KODAMA algorithm from the R package of the same name (V.1.4) (68). Measurements of alpha
diversity and calculations of relative abundances were also performed with the vegan package. Relative-
abundance data were generated separately for identiﬁed species within each phylogenetic domain (e.g.,
Bacteria).
For metabolomic analysis, the resulting 1H-NMR and LC-MS data sets were imported into MatLab to
conduct multivariate statistical analysis. Data were centered and scaled to account for the repeated-
measures design and then modeled using partial-least-squares–discriminant analysis (PLS-DA) with
Monte Carlo cross-validation (MCCV) (69). The ﬁt and predictability of the models obtained were
determined and expressed as R2 and Q2 values, respectively.
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Data availability. The microbial DNA sequences have been deposited in the European Nucleotide
Database (ENA) database under ID code PRJEB20054.
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